SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-027448
Filing Date
2021-11-08
Accepted
2021-11-08 06:35:31
Documents
70
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1025764
2 ex31-1.htm EX-31.1 11353
3 ex31-2.htm EX-31.2 11362
4 ex32-1.htm EX-32.1 7951
5 form10-q_001.jpg GRAPHIC 4845
  Complete submission text file 0001493152-21-027448.txt   4874787

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE mtnb-20210930.xsd EX-101.SCH 40509
7 XBRL CALCULATION FILE mtnb-20210930_cal.xml EX-101.CAL 56062
8 XBRL DEFINITION FILE mtnb-20210930_def.xml EX-101.DEF 134898
9 XBRL LABEL FILE mtnb-20210930_lab.xml EX-101.LAB 329195
10 XBRL PRESENTATION FILE mtnb-20210930_pre.xml EX-101.PRE 257357
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 703283
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38022 | Film No.: 211386446
SIC: 2834 Pharmaceutical Preparations